Dentsply Sirona Reports Profitability Turnaround Amid Declining Sales
On August 6, Dentsply Sirona (NASDAQ:XRAY) reported a net income of $37 million for the second quarter of 2026, reversing from a $45 million loss in the same period last year. Despite this improvement, sales fell by 4.1% to $898 million on an annual basis and dropped further when adjusted for currency effects (down 6.3%). The company's gross margin improved significantly, climbing to 54.9%, while cash flow metrics also showed strong gains. Operating cash flow surged to $99 million from $48 million in the prior year quarter due to tariff refunds and better inventory management. Free cash flow more than tripled to $55 million. The company used some of this capital for share repurchases, buying back 1.3 million shares worth about $12 million during the period. Despite these improvements, Dentsply Sirona reiterated its full-year sales guidance between $3.5 billion and $3.6 billion while facing ongoing challenges in key segments like Orthodontic and Implant Solutions.
Tickers: $XRAY
Topics: cash flow improvement earnings profitability turnaround sales decline